Cargando…
Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649366/ http://dx.doi.org/10.1186/2051-1426-3-S2-P331 |
| _version_ | 1782401342726209536 |
|---|---|
| author | Annels, Nicola E Simpson, Guy Arif, Mehreen Denyer, Mick Iqbal, Attya Mansfield, David Sandhu, Sarbjinder Melcher, Alan Harrington, Kevin Au, Gough Grose, Mark Shafren, Darren Mostafid, Hugh Pandha, Hardev |
| author_facet | Annels, Nicola E Simpson, Guy Arif, Mehreen Denyer, Mick Iqbal, Attya Mansfield, David Sandhu, Sarbjinder Melcher, Alan Harrington, Kevin Au, Gough Grose, Mark Shafren, Darren Mostafid, Hugh Pandha, Hardev |
| author_sort | Annels, Nicola E |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649366 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46493662015-11-24 Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21 Annels, Nicola E Simpson, Guy Arif, Mehreen Denyer, Mick Iqbal, Attya Mansfield, David Sandhu, Sarbjinder Melcher, Alan Harrington, Kevin Au, Gough Grose, Mark Shafren, Darren Mostafid, Hugh Pandha, Hardev J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649366/ http://dx.doi.org/10.1186/2051-1426-3-S2-P331 Text en Copyright © 2015 Annels et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Annels, Nicola E Simpson, Guy Arif, Mehreen Denyer, Mick Iqbal, Attya Mansfield, David Sandhu, Sarbjinder Melcher, Alan Harrington, Kevin Au, Gough Grose, Mark Shafren, Darren Mostafid, Hugh Pandha, Hardev Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21 |
| title | Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21 |
| title_full | Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21 |
| title_fullStr | Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21 |
| title_full_unstemmed | Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21 |
| title_short | Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21 |
| title_sort | oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus a21 |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649366/ http://dx.doi.org/10.1186/2051-1426-3-S2-P331 |
| work_keys_str_mv | AT annelsnicolae oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 AT simpsonguy oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 AT arifmehreen oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 AT denyermick oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 AT iqbalattya oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 AT mansfielddavid oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 AT sandhusarbjinder oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 AT melcheralan oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 AT harringtonkevin oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 AT augough oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 AT grosemark oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 AT shafrendarren oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 AT mostafidhugh oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 AT pandhahardev oncolyticimmunotherapyforthetreatmentofnonmuscleinvasivebladdercancerusingintravesicalcoxsackievirusa21 |